MOG Polyclonal Antibody

The product of this gene is a membrane protein expressed on the oligodendrocyte cell surface and the outermost surface of myelin sheaths. Due to this localization, it is a primary target antigen involved in immune-mediated demyelination. This protein may be involved in completion and maintenance of the myelin sheath and in cell-cell communication. Alternatively spliced transcript variants encoding different isoforms have been identified.

The MOG Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of myelin oligodendrocyte glycoprotein (MOG) in various biological samples. This antibody is produced using state-of-the-art technology and has been extensively validated to ensure its superior performance and accuracy.

With its exceptional sensitivity and specificity, the MOG Polyclonal Antibody enables researchers to investigate the role of MOG in various physiological and pathological processes. It is particularly useful in studies related to multiple sclerosis, as MOG has been identified as a key autoantigen in this debilitating neurological disorder.

The MOG Polyclonal Antibody exhibits excellent performance in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. Its high affinity and selectivity allow for precise and reliable detection of MOG, even at low concentrations.

Furthermore, this antibody is manufactured under strict quality control standards to ensure batch-to-batch consistency and reproducibility. It is supplied in a convenient and ready-to-use format, eliminating the need for time-consuming preparation steps.

In summary, the MOG Polyclonal Antibody is a valuable tool for researchers seeking to explore the role of MOG in various biological processes. Its exceptional sensitivity, specificity, and reliability make it an indispensable asset in the field of neuroscience and immunology.